1. Home
  2. CRIS vs CALC Comparison

CRIS vs CALC Comparison

Compare CRIS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • CALC
  • Stock Information
  • Founded
  • CRIS 2000
  • CALC 2011
  • Country
  • CRIS United States
  • CALC United States
  • Employees
  • CRIS N/A
  • CALC N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRIS Health Care
  • CALC Health Care
  • Exchange
  • CRIS Nasdaq
  • CALC Nasdaq
  • Market Cap
  • CRIS 32.8M
  • CALC 36.0M
  • IPO Year
  • CRIS 2000
  • CALC N/A
  • Fundamental
  • Price
  • CRIS $3.25
  • CALC $2.55
  • Analyst Decision
  • CRIS Strong Buy
  • CALC Strong Buy
  • Analyst Count
  • CRIS 3
  • CALC 5
  • Target Price
  • CRIS $23.00
  • CALC $18.20
  • AVG Volume (30 Days)
  • CRIS 33.0K
  • CALC 31.7K
  • Earning Date
  • CRIS 02-18-2025
  • CALC 03-27-2025
  • Dividend Yield
  • CRIS N/A
  • CALC N/A
  • EPS Growth
  • CRIS N/A
  • CALC N/A
  • EPS
  • CRIS N/A
  • CALC N/A
  • Revenue
  • CRIS $10,259,000.00
  • CALC N/A
  • Revenue This Year
  • CRIS N/A
  • CALC N/A
  • Revenue Next Year
  • CRIS N/A
  • CALC N/A
  • P/E Ratio
  • CRIS N/A
  • CALC N/A
  • Revenue Growth
  • CRIS 0.44
  • CALC N/A
  • 52 Week Low
  • CRIS $2.86
  • CALC $2.05
  • 52 Week High
  • CRIS $17.49
  • CALC $6.27
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 45.26
  • CALC 45.07
  • Support Level
  • CRIS $3.05
  • CALC $2.45
  • Resistance Level
  • CRIS $3.55
  • CALC $2.75
  • Average True Range (ATR)
  • CRIS 0.18
  • CALC 0.20
  • MACD
  • CRIS -0.01
  • CALC 0.01
  • Stochastic Oscillator
  • CRIS 32.69
  • CALC 48.21

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Share on Social Networks: